Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)
China · Delayed Price · Currency is CNY 15.22
+0.01 (0.07%)
May 6, 2026, 3:04 PM CST
SHE:300181 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 660.88 | 642.44 | 507.77 | 382.94 | 273.01 | 179.41 |
Depreciation & Amortization | 80.68 | 80.68 | 70.7 | 64.92 | 60.51 | 57.17 |
Other Amortization | 3.79 | 3.79 | 4.74 | 3.58 | 3.37 | 2.47 |
Loss (Gain) From Sale of Assets | -0.59 | -0.59 | -0.35 | -0.28 | -1.72 | -0.24 |
Asset Writedown & Restructuring Costs | 12.32 | 12.32 | 8.06 | 0.53 | 11.44 | 2.16 |
Loss (Gain) From Sale of Investments | 1.7 | 1.7 | 0.66 | 0.1 | -1.48 | -1.72 |
Provision & Write-off of Bad Debts | - | - | 6.25 | 0.85 | 5.24 | 1.2 |
Other Operating Activities | 160.17 | 21.17 | 29.99 | 18.18 | 24.26 | 28.39 |
Change in Accounts Receivable | -335.15 | -335.15 | -307.22 | -27.64 | -207.99 | -60.91 |
Change in Inventory | -19.08 | -19.08 | -108.51 | -99.15 | -61.54 | -76.15 |
Change in Accounts Payable | -38.12 | -38.12 | 89.23 | -53.81 | 216.41 | 127.09 |
Change in Other Net Operating Assets | 44.73 | 44.73 | - | - | - | - |
Operating Cash Flow | 569.25 | 411.8 | 297.05 | 288.46 | 318.59 | 251.8 |
Operating Cash Flow Growth | 181.05% | 38.63% | 2.98% | -9.46% | 26.53% | -9.97% |
Capital Expenditures | -213.49 | -287.14 | -262.89 | -131.71 | -178.03 | -147.95 |
Sale of Property, Plant & Equipment | 0.9 | 0.89 | 1 | 2.43 | 5.87 | 0.1 |
Investment in Securities | -172.5 | -125 | 151 | -140.25 | 54.25 | 103.2 |
Other Investing Activities | - | - | 0.64 | 5.95 | 4.58 | 7.76 |
Investing Cash Flow | -385.09 | -411.25 | -110.25 | -263.58 | -113.34 | -36.89 |
Long-Term Debt Issued | - | 798.7 | 529.16 | 259.7 | 252 | 237 |
Long-Term Debt Repaid | - | -565 | -328.96 | -208.79 | -285.9 | -410.82 |
Net Debt Issued (Repaid) | 211.4 | 233.7 | 200.2 | 50.91 | -33.9 | -173.82 |
Issuance of Common Stock | - | - | 2.22 | - | 898.14 | - |
Repurchase of Common Stock | - | - | -203.97 | - | - | - |
Common Dividends Paid | -417.34 | -423.89 | -320.8 | -213.11 | -145.16 | -70.28 |
Other Financing Activities | 19.74 | 72.99 | -17.04 | 2.88 | -75.98 | 1.15 |
Financing Cash Flow | -186.2 | -117.21 | -339.39 | -159.32 | 643.1 | -242.95 |
Foreign Exchange Rate Adjustments | -0 | -0 | 0 | 0 | -0 | - |
Net Cash Flow | -2.05 | -116.66 | -152.59 | -134.43 | 848.35 | -28.04 |
Free Cash Flow | 355.75 | 124.66 | 34.16 | 156.75 | 140.56 | 103.84 |
Free Cash Flow Growth | - | 264.94% | -78.21% | 11.52% | 35.35% | -53.08% |
Free Cash Flow Margin | 11.42% | 4.10% | 1.32% | 8.07% | 7.79% | 7.12% |
Free Cash Flow Per Share | 0.51 | 0.18 | 0.05 | 0.23 | 0.23 | 0.17 |
Cash Interest Paid | - | - | 0.16 | 0.11 | 0.1 | - |
Cash Income Tax Paid | 362.26 | 324.68 | 284.42 | 226.29 | 198.22 | 173.88 |
Levered Free Cash Flow | 408.81 | -41.95 | -137.32 | 64.03 | 70.68 | 172.04 |
Unlevered Free Cash Flow | 408.81 | -41.95 | -131.51 | 68.79 | 75.88 | 179.59 |
Change in Working Capital | -349.69 | -349.69 | -330.77 | -182.35 | -56.02 | -17.05 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.